BiondVax Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch BVXV and buy or sell other stocks, ETFs, and their options commission-free!

About BVXV

Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza.

CEO

Amir Reichman, MBA

CEOAmir Reichman, MBA

Employees

—

Employees—

Headquarters

Jerusalem, Jerusalem

HeadquartersJerusalem, Jerusalem

Founded

2003

Founded2003

Employees

—

Employees—

BVXV Key Statistics

Market cap

1.16M

Market cap1.16M

Price-Earnings ratio

7.93

Price-Earnings ratio7.93

Dividend yield

—

Dividend yield—

Average volume

17.70K

Average volume17.70K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$8.92

52 Week high$8.92

52 Week low

$1.90

52 Week low$1.90